Clinical trial
Study of BioNIR Drug Eluting Stent System in Coronary Stenosis
NCT01995487 · Medinol Ltd., Industry · Completed
Key facts
| NCT number | NCT01995487 |
|---|---|
| Title | Study of BioNIR Drug Eluting Stent System in Coronary Stenosis |
| Official title | BioNIR Ridaforolimus Eluting Coronary Stent System (BioNIR) In Coronary Stenosis Trial |
| Acronym | BIONICS |
| Lead sponsor | Medinol Ltd., Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Coronary Artery Stenosis |
| Intervention type | Device |
| Interventions | BioNIR, Resolute |
| Enrollment | 1,919 |
| Start date | Jan 1, 2014 |
| Primary completion | Aug 28, 2016 |
| Completion | Nov 30, 2020 |
| First posted | Nov 26, 2013 |
| Last update posted | Oct 16, 2023 |
| Countries | Belgium, Canada, Israel, Italy, Netherlands, Poland, Spain, United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: